225 related articles for article (PubMed ID: 31116487)
1.
Papadakis GZ; Manikis GC; Karantanas AH; Florenzano P; Bagci U; Marias K; Collins MT; Boyce AM
J Bone Miner Res; 2019 Sep; 34(9):1619-1631. PubMed ID: 31116487
[TBL] [Abstract][Full Text] [Related]
2. Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.
van der Bruggen W; Hagelstein-Rotman M; de Geus-Oei LF; Smit F; Dijkstra PDS; Appelman-Dijkstra NM; Vriens D
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1527-1537. PubMed ID: 31875244
[TBL] [Abstract][Full Text] [Related]
3. Quantitative
Coskun N; Cagdas B; Yildirim N
Hell J Nucl Med; 2022; 25(2):132-137. PubMed ID: 35913859
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
[TBL] [Abstract][Full Text] [Related]
6. Uptake of Radium-223 Dichloride and Early [
Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
[TBL] [Abstract][Full Text] [Related]
7. Use of
Jeon TJ; Kim S; Park J; Park JH; Roh EY
BMC Med Imaging; 2018 Sep; 18(1):34. PubMed ID: 30236078
[TBL] [Abstract][Full Text] [Related]
8. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
Iagaru A; Mittra E; Dick DW; Gambhir SS
Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
[TBL] [Abstract][Full Text] [Related]
10. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
12. A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity.
Jreige M; Hall N; Becce F; Aubry-Rozier B; Gonzalez Rodriguez E; Schaefer N; Prior JO; Nicod Lalonde M
Front Med (Lausanne); 2022; 9():1050854. PubMed ID: 36507503
[TBL] [Abstract][Full Text] [Related]
13. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
14. Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.
Lapa P; Marques M; Costa G; Iagaru A; Pedroso de Lima J
Nucl Med Commun; 2017 Apr; 38(4):325-332. PubMed ID: 28230714
[TBL] [Abstract][Full Text] [Related]
15. The Utility of 18 F-NaF-Positron Emission Tomography/Computed Tomography in Measuring the Metabolic Activity of the Aging Spine : Implications for Osteoporosis.
Park PSU; Resto DA; Khurana N; Raynor WY; Werner TJ; Høilund-Carlsen PF; Alavi A
Spine (Phila Pa 1976); 2023 Aug; 48(15):1064-1071. PubMed ID: 36972138
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Assessment of Early [
Harmon SA; Perk T; Lin C; Eickhoff J; Choyke PL; Dahut WL; Apolo AB; Humm JL; Larson SM; Morris MJ; Liu G; Jeraj R
J Clin Oncol; 2017 Aug; 35(24):2829-2837. PubMed ID: 28654366
[TBL] [Abstract][Full Text] [Related]
17. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
18. Quantitative [
Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
20. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]